Ioana Agache
Professor of Allergy and Clinical Immunology at Transylvania University, Brasov, Romania and Past President of the European Academy of Allergy and Clinical Immunology (EAACI) 2017-2019 and past Chair of the EAACI Research and Outreach Committee.
Her research in the field of Asthma and Allergy and Clinical Immunology focuses on asthma phenotypes and endotypes, biomarkers, immune modulation, AI/machine-learning and integrated management of allergic diseases, with a special focus on exposomics and One Health. Ioana Agache is leading the EAACI guidelines on Biologics and is a member of the Steering Committee and co-author of several international and European Guidelines, such as ARIA (Allergic Rhinitis and its impact on Asthma), EAACI Allergen Immunotherapy Guidelines and EAACI Food Allergy and Anaphylaxis Guidelines.
She is Editor of several books: Implementing Precision Medicine in Best Practices of Chronic Airway Diseases (2018) Global Atlas of Asthma (2013), Global Atlas of Allergy (2014), Global Atlas of Allergic Rhinitis and Chronic Rhinosinusitis (2015), Associate Editor of Clinical and Translational Allergy and a member of the Editorial Board for Allergy and Journal of Allergy and Clinical Immunology. Ioana Agache graduated with a medical degree from “Carol Davila” University, Bucharest and absolved Magna Cum Laude her PhD in Internal Medicine.
Andreas Bonertz
Dr. Andreas Bonertz is Head of Section Clinical Trials at the Paul-Ehrlich-Institute, Langen, Germany
Current Activities:
- Coordination of national and multi-national clinical trial applications and follow-up-procedures
- Member of the EMA Rheumatology and Immunology Working Party (RIWP)
- Member of the Clinical Trial Coordination Group of the Heads of Medicines Agencies (CTCG)
CV:
- Since 2023 - Head of Section Clinical Trials, Paul-Ehrlich-Institute, Langen, Germany
- 2011 – 2023 Head of Section Test and Therapy Allergens, Paul-Ehrlich-Institute, Langen, Germany
- 2010-2011 National Center for Tumour Diseases, Heidelberg, Germany
Radosław Gawlik
Professor Radosław Gawlik, MD, PhD is Head of Dpt. and Chair Internal Medicine, Allergology, Clinical Immunology, Medical University of Silesia, Poland
President of Polish Society of Allergology
Chair of Specialty Committee European Academy of Allergology and Clinical Immunology (EAACI)
My main research interests focus on Asthma treatment, biologics, Allergen immunotherapy, Hymenoptera Venom Allergy, quality of life in allergic patients, drug allergy and novel treatments in allergy. I work with primary care physician on coordinated patient care and education. Implementing of new IT tools in patient management is important part of my current activities.
Steve N. Georas
Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA
Steve N. Georas is Walter and Carmina Parkes Family Endowed Professor, Professor of Medicine, Environmental Medicine, and Microbiology/Immunology Division of Pulmonary and Critical Care Medicine
Dr. Georas has a long-standing interest in Type 2 immune dysregulation and currently directs a research group investigating mechanisms and consequences of epithelial barrier dysfunction in asthma. He has published widely on these topics and is active in peer review, and currently serves on the Editorial Board of the Journal of Allergy and Clinical Immunology. He co-chairs the Steering Committee for the PrecISE Asthma Network, which conducted an innovative adaptive platform study of five interventions in severe and exacerbation prone asthma. He obtained his medical degree at Brown University and did an internship and residency in internal medicine at Duke University Medical Center, followed by training in Pulmonary & Critical Care Medicine at Johns Hopkins University. Clinical activities include caring for patients with critical illness in the intensive care unit, as well as an outpatient practice of adults with severe asthma.
Karina Jahnz-Różyk
Head of the Department of Internal Diseases, Pneumonology, Allergology, Clinical Immunology and Rare Diseases of the Military Institute of Medicine - National Research Institute, Warsaw, Poland
Professor Karina Jahnz-Różyk, MD, PhD is a specialist in internal medicine, pneumonology, allergology and clinical immunology.
Main activities:
• Care for patients after COVID-19 (mainly in patients with complications in lung diseases)
• Implementation of drug programs in allergology (severe asthma - biological treatment, chronic spontaneous urticaria, atopic dermatitis, angioedema). In 2022 -2024 many positive decisions of the Minister of Health were made (introduced after consultations with the National Consultant), introducing new biological and innovative drugs for patients with allergic diseases, as well as many positive changes in the descriptions of drug programs, increasing the availability of these drugs
• Implementation of drug programs in clinical immunology (autoinflammatory diseases, primary immunodeficiencies), supervision over the implementation resulting from the function of the chairman of the Section of Autoinflammatory Diseases and Angioedema, operating at the Coordinating Team for Rare Diseases
• Participation as a consultant in the Plasma Protein Therapeutic Association (member of the European Immunoglobulin Advisory Board).
Marek Jutel
Head of the Department and Clinical Immunology at the Wroclaw Medical University, and Director of ALL-MED Medical Research Institute in Wroclaw, Poland and affiliate professor at Harvard University, Department of Environmental Health, Health, School of Public Health.
Marek Jutel is currently a professor of allergy, clinical immunology, and internal medicine.
He served as President of the European Academy of Allergy and Clinical Immunology (EAACI) 2019-2022 and was EAACI ExCom member 2009-2024. He is Deputy-Editor of the journal “Allergy” and associate Editor of Clinical and Translational Allergy and a member of the editorial boards of 10 other journals. Prof. Jutel’s research has been focused on immune tolerance mechanisms, especially in the model of allergen-specific immunotherapy (AIT). He is also constantly involved in clinical research on immunotherapy, biologics, and pharmacotherapy in allergic diseases, asthma, and COPD. He pioneered the use of recombinant allergens in the diagnosis and treatment of allergic diseases. He was the principal investigator in more than 50 clinical trials in allergy, asthma, COPD, and other immune-mediated diseases.
Prof. Jutel has authored more than 300 scientific articles and 50 books and book chapters. He constantly contributes to a large number of guidelines and position papers on the management of allergic and immune-mediated diseases published by EAACI and other scientific organizations.
Maciej Kupczyk
Maciej Kupczyk, MD, PhD, is a Professor at the Department of Internal Medicine, Asthma, and Allergy at the Medical University of Łódź, affiliated with Barlicki University Hospital, Poland.
He gained scientific experience during internships at Huddinge Sjukhus, Stockholm (1999) and Ospedale Luigi Sacco, Milan (2000). Post-doc, Allergy Research Center, Karolinska Institute, Stockholm (2008–2011).
His main scientific interests focus on problems related to severe asthma, allergology, specific immunotherapy, drug hypersensitivity. Member of scientific societies including the Polish Society of Allergology, Polish Society of Lung Diseases, European Academy of Allergy and Clinical Immunology and European Respiratory Society. President of the Polish Society of Allergology (PTA) (term of office 2021–2024), in 2018–2021 President Elect of PTA, member of the Main Board of PTA, chairman of the Łódź Branch of PTA (2015–2018). He is an author of over 190 publications.
Marcin Moniuszko
Professor Marcin Moniuszko, MD, PhD is Head of the Department of Allergology and Internal Medicine and the Department of Regenerative Medicine and Immunoregulation at the Medical University of Białystok, Poland.
In 1999 he graduated with distinction from the Medical Academy in Białystok in the field of medicine, since 2004 he has been working in the Department of Allergology and Internal Medicine, and in 2018 he became its head. Immediately after graduation he completed numerous scientific internships, including 3 years at the National Institutes of Health (Bethesda, USA). He has specialization in internal medicine and allergology.
Since 2012 he has been the head of the newly established Department of Regenerative Medicine and Immunoregulation at UMB. Together with the first members of the team and clinical teams of UMB, they published a series of works describing the role of stem and progenitor cells such as VSELs, HSCs or EPCs and individual subpopulations of monocytes and T and B lymphocytes in the pathogenesis of neoplastic, allergic, autoimmune, metabolic and other diseases. In addition, he conducted a number of studies on new immunological and hormonal factors influencing the mobilization and proliferation of stem cells, cancer cells and monocytes and T lymphocytes. He is also a co-author of numerous works describing the role of changes in the genomic and metabolome profile in the pathogenesis, course and response to treatment of a number of civilization diseases.
On March 15, 2024, he was elected rector of the Medical University of Białystok. He is the vice-president of the Polish Society of Allergology.
Ralph Mösges
Institute of Medical Statistics and Computational Biology Medical Faculty University at Cologne AND ClinCompetence Cologne GmbH, Germany.
University Professor Dipl.-Ing. Ralph Mösges, M.D. Ph.D. FAAAAI an otorhinolaryngologist and allergologist, Master of Public Administration with a specialist degree and habilitation in Medical
Informatics is the director and owner of Clinical Research International Ltd. Hamburg and managing director of ClinCompetence GmbH Cologne, two organizations specialized in research for private contractors and public authorities in the fields of allergology and otorhinolaryngology. He was until 2017 the chairman of the Institute of Medical Statistics, Informatics and Epidemiology at the University Hospital of Cologne, Germany.
His current research fields are allergic and infectious diseases of the upper airways, epidemiology, and clinical pharmacology.
Ralph Mösges is the author and editor of ten books and has published more than 400 articles in renowned journals. He holds German and international patents in Computer Assisted Surgery.
Manali Mukherjee
Assistant Professor of Medicine, Division of Respirology, McMaster University
She has demonstrated expertise in investigating inflammatory mechanisms of chronic respiratory diseases, in particular autoimmunity, response to treatment and development/ validation of clinical biomarkers. Her research has identified the presence of localized autoimmune responses in the airways of patients with complex airways disease and determined their pathogenic role in driving disease severity. Of recent, she has identified autoimmune responses in acute-severe COVID and linked autoimmunity with post-acute COVID-19 sequelae (or Long COVID). In the field of respiratory medicine, she published ~65 manuscripts, and in the past 5 years these have accumulated >2000 citations.
Dr. Mukherjee’s research program focuses on “Lung autoimmunity and biomarkers”. She is the past recipient of the Emerging Researcher Award in Allergic Asthma awarded conjointly by the Canadian Institutes of Health Research (CIHR) and the Canadian Asthma, Allergy and Immunology Foundation (CAAIF). Her lab is funded by federal and non-federal sources including CIHR-ICRH and industry. Dr Mukherjee was recently named the AstraZeneca Chair in Respiratory Diseases (2023-2028).
Current ongoing projects span from investigating mechanisms of disease to validating biomarkers in asthma, eGPA, COVID-19, and lung cancer.
Parameswaran Nair
Professor Parameswaran Nair MD, PhD, FRCP, FRCPC, FCAHS
Dr Nair is the Frederick E. Hargreave Teva Innovation Chair in Airway Diseases & Professor of Medicine in the Division of Respirology at McMaster University in Hamilton, Ontario, Canada, providing tertiary care, at the Firestone clinic, to patients with severe asthma and other complex airway and eosinophilic lung diseases.
He directs a patient-centred translational research program focussed on charactering bronchitis using sputum biomarkers, and targeted therapy with biologics and small molecule antagonists. The research program has been recognized by a Canada Research Chair, The American Thoracic Society’s Ann Woolcock Award, The Asthma Society of Canada’s Bastable Potts Award, Fellowships of the Canadian Academy of Health Sciences, The European Respiratory Society, The American College of Chest Physicians, and Memberships of the Collegium Internationale Allergologicum and National Academy of Medical Sciences of India. His laboratory has contributed to over 350 peer-reviewed publications in high impact general medical, allergy, and respiratory journals (h-index 78).
Alberto Papi
Alberto Papi is Professor of Respiratory Medicine at the University of Ferrara, Italy.
His main research areas are airway inflammation and respiratory viral infections. He is Member of the GOLD Science Committee. He has coordinated several pivotal studies and has authored more than 600 articles in peer-reviewed journals.
His research primarily focuses on airway inflammation in asthma and chronic obstructive pulmonary disease (COPD), exploring molecular mechanisms and pharmacological interventions. He also explores precision medicine, lung microbiota, and the impact of air pollution to improve patient outcomes in respiratory diseases.
Marek Sanak
Professor Marek Sanak, MD, PhD is Head of Division of Molecular Biology and Clinical Genetics, Department of Internal Medicine, Jagiellonian University Medical College, Cracow, Poland
Research interests
Biomarkers of inflammation, particularly allergic inflammation and inflammation associated with vascular disease. Non-invasive biological material such as exhaust air condensate and urine. Analytical techniques based on high-performance liquid chromatography or gas chromatography combined with mass spectrometry. Research in collaboration with the University of Oslo, Davos Institute for Asthma and Allergy Research, International consortium U-BIOPRED. Member of the Task Force of the European Academy of Allergy and Clinical Immunology (EAACI) on inflammatory mediators. Past editor of the journal Allergy and Clinical and Experimental Allergy. Past member of the State Examination Board for Allergology.
Magdalena Zemelka-Wiacek
Dr. Magdalena Zemelka-Wiącek, PhD, is a University Professor at the Department of Clinical Immunology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland.
Her research focuses on allergen immunotherapy and the use of allergen exposure chambers (AECs) for assessments in allergic rhinitis and asthma. As Principal Investigator, she leads research project on environmental pollutants - the impact of nanoplastics on immune function, investigating their penetration into biological systems and potential health effects.
She is actively involved in the European Academy of Allergy and Clinical Immunology (EAACI) as Science Committee Secretary and a Board Member of the Epidemiology Working Group. She also contributes to Position Papers and Guidelines on allergy, asthma, and One Health and environmental health. Additionally, she serves on the Editorial Board of the journal “Allergy”.
Besides her research and publishing activities, she is engaged in mentoring and teaching, supervising PhD and master’s students.
Ali Ӧnder Yldirim
Dr Ali Önder Yildirim, PhD, is a Director of Institute of Lung Health and Immunity (LHI), Comprehensive Pneumology Center (CPC), Helmholtz Munich and Professor at Institute of Experimental Pneumology, Ludwig-Maximilians University (LMU), Munich, Germany.
AÖY is a renowned expert in chronic lung disease with expertise in immunology, lung pathology, and drug discovery. As Director of the Institute of Lung Health and Immunity and a professor at LMU Munich, AÖY leads groundbreaking research on B cell-driven immune activation in COPD, LTx, and IPF. Their work on lymphotoxin signaling and alveolar regeneration has influenced novel therapeutic strategies. AÖY has mentored numerous researchers and collaborates globally, publishing in top-tier journals like Nature and Allergy.
.png)